Recently, Arcos-Montoya et al. reported that the PR content, determined with immunofluorescence, was higher in samples derived from patients with GBs than in samples from patients with lower-grade gliomas or normal tissue [55]. The gene discussed is PGR; the disease is central nervous system cancer.